alendronate has been researched along with Alloxan Diabetes in 4 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Even if postmenopausal osteoporosis is accompanied by diabetes in this animal model, both alendronate and raloxifene seem to show antiresorptive effects, decreased bone turnover rates, and improved bone mechanical strength." | 1.48 | Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model. ( Cho, DC; Gupta, R; Han, I; Kim, CH; Kim, KT; Kwon, JT; Lee, YS; Park, EK; Seo, YJ; Seu, SY; Sung, JK, 2018) |
| "Alendronate was also able to reduce marrow adiposity in both control diabetic mice compared to untreated mice." | 1.42 | Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation. ( Baumann, MJ; Coe, LM; McCabe, LR; Shu, Y; Tekalur, SA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GP | 1 |
| Zhang, XQ | 1 |
| Wu, T | 1 |
| Han, J | 1 |
| Ye, D | 1 |
| Lee, YS | 1 |
| Gupta, R | 1 |
| Kwon, JT | 1 |
| Cho, DC | 1 |
| Seo, YJ | 1 |
| Seu, SY | 1 |
| Park, EK | 1 |
| Han, I | 1 |
| Kim, CH | 1 |
| Sung, JK | 1 |
| Kim, KT | 1 |
| Berti-Couto, SA | 1 |
| Vasconcelos, AC | 1 |
| Iglesias, JE | 1 |
| Figueiredo, MA | 1 |
| Salum, FG | 1 |
| Cherubini, K | 1 |
| Coe, LM | 1 |
| Tekalur, SA | 1 |
| Shu, Y | 1 |
| Baumann, MJ | 1 |
| McCabe, LR | 1 |
4 other studies available for alendronate and Alloxan Diabetes
| Article | Year |
|---|---|
Inhibition of farnesyl pyrophosphate synthase attenuates high glucose‑induced vascular smooth muscle cells proliferation.
Topics: Alendronate; Animals; Aorta; Blood Glucose; Cell Proliferation; Cells, Cultured; Chromatography, Hig | 2017 |
Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
Topics: Alendronate; Animals; Biomarkers; Bone Density; Bone Remodeling; Collagen Type I; Diabetes Mellitus, | 2018 |
Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: a study in Wistar rats.
Topics: Adrenal Cortex Hormones; Alendronate; Animals; Biopsy, Needle; Bisphosphonate-Associated Osteonecros | 2014 |
Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
Topics: Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Bone Resorption; Diabetes Mell | 2015 |